0000899243-21-003869.txt : 20210201 0000899243-21-003869.hdr.sgml : 20210201 20210201165205 ACCESSION NUMBER: 0000899243-21-003869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210129 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Corcoran Andrea CENTRAL INDEX KEY: 0001296996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 21577437 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-29 0 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001296996 Corcoran Andrea 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 0 1 0 0 See Remarks Stock Option (Right to Buy) 73.00 2021-01-29 4 A 0 148850 0.00 A 2031-01-28 Common Stock 148850 148850 D The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Chief Financial Officer, Executive Vice President, Legal and Secretary /s/ Andrea Corcoran 2021-02-01